Below is my response to H_dog_taco on the other board.

New Post Public Reply Private Reply Replies (0) Message Board
BruceLake
1,174
Below is my response to H_dog_taco on the other board. Much is being said about possible joint ventures and mergers. Somehow they think that because Stanley Hirsch is the COB of both Foamix and OWC, it's a foregone conclusion that at some point this may become a reality. Being the prick that he is, that may very well suit his original agenda of building "massive value" for himself and screw shareholders in the process. Good news is that notwithstanding his title, he has limited influence with OWC, and very little with Foamix. David Domzalski, their CEO calls all the shots. Also it's not a certainty that Stanley Hirsch will continue to be on the BOD, let alone be its chairman.

Response to H_dog_taco:
You’ve raised some issues that are being talked about a lot. Below are my observations and clarification to some of them.

1: The marketing/sales lady being referred to is Miri Chen. She may have a lot of connections, but the last time I checked she was looking for a job. Her linkedin states that she is “seeking for new opportunity in Marketing/Buisness Development in the Pharma/Medical Device/Medical Cannabis industry”. https://il.linkedin.com/in/mirichen?trk=publi...full-click

2: Cannot argue with your comment that they treat “current shareholders like complete shit”.

3: We continue to check their website and it is true that the company has really no interest in updating it. It’s also true that their twitter page has gone MIA. The login info remains with their so-called former advisor from Florida, aka a certified idiot. If you look at the bottom right of the company’s website you will notice a linkedin link. The link gives us the names of two employees at OWC Pharma. One is Yonit Tsarfati, listed as a Project Manager, and the other is Hilla Kochavi, listed as the Manager of Marketing at Kinarti. Hilla also goes by the name Hilla Kochavi-Zeevi. I believe their last post and reference to OWC was back in September. It’s obvious their position, if you want to call it that, with OWC is very informal and part-time.

4: To me it doesn’t scream a buyout/merger, not yet anyway.

5: OWC Pharma did not bail on the Stenocare MOU. It was the other way around. However, in retrospect my view on that is that OWC Pharma is better off without Stenocare. Especially considering that since the announcement they received the patent grant. They are now free to pursue other options, whatever those may be.

6: I sure as hell hope that Foamix stays away from OWC Pharma. Not everybody is happy with the Menlo Therapeutics merger. The exchange of shares between the two companies translates to an 18% premium to Menlo Shareholders. That is the good news and the best-case scenario. Built into the agreement is a contingent stock right that hinges on the result of two phase 3 clinical trials. A lot of fingers will be crossed!
http://www.foamix.com/news-releases/news-rele...ed-company

7: Speaking of crossed fingers, some of us have crossed them for so long that they have become permanently fused. As a consequence I’ve stopped believing in tea leaves!

8: Yes, the best advice is to do your own DD and take all the hype and riff raff with a grain of salt.

OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links

OWCP Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Foresight Solar Insurance Trial Beats Fixed PPA Route

Updated Category News Views 72

Six solar sites and one settled insurance contract have produced a result worth studying, not celebrating with confetti. Foresight and Paratus say their completed renewable-price insurance policy generated a £14.49/MWh net uplift, after premium, against the revenue those assets would have earned under a fixed-price power purchase agreement. In a UK renewables market...

Continue Reading
PPL's January Dividend Keeps Utility Appeal Intact

Updated Category News Views 85

A dividend notice is rarely thrilling, but it can still separate a steady utility from a story stock peddling fumes. PPL Corporation declared a quarterly common dividend of $0.2850 per share on Nov. 20, payable Jan. 4, 2027. Shareholders must be on the books by Dec. 10, 2026, to receive it. Plain vanilla stuff, yes. Still, plain vanilla is often precisely why utility...

Continue Reading
Straub's Court Win Raises Cost of Seven-Year Fight

Updated Category News Views 51

Seven years of courtroom smoke over an under-$80,000 lien is the sort of mess that makes any business owner grind his teeth. Palm Beach Polo says its president, Glenn Straub, has again prevailed against Jessica Nicodemo in Palm Beach County, following an earlier Broward County dismissal of related claims. The company also says Vice President Sal Spano received a directed...

Continue Reading
Milwaukee County Contract Tests Wisconsin Labor Shift

Updated Category News Views 6

A unanimous first contract in a Milwaukee County department is not the sort of headline that rattles a trading screen, but it can tell you plenty about where the ground is moving. Public safety workers in the county Facilities Department have ratified their first agreement with Teamsters Local 344, according to the union. The vote matters less for any disclosed economic...

Continue Reading
Frost & Sullivan’s 65 Years Put APAC Growth on Display

Updated Category News Views 95

A Crowded Singapore Room Says Something Singapore did not host a mere anniversary toast on November 18; it hosted a pretty revealing cross-section of the businesses trying to build, secure, cool, connect, finance, and digitize Asia Pacific and MEASA. Frost & Sullivan marked 65 years with its 2026 Best Practices Recognition banquet at Hilton Singapore Orchard, gathering...

Continue Reading
Great Rail Journeys Bets Bigger on Luxury Rail in 2027

Updated Category News Views 99

A $19,995 vacation is not selling a seat on a train; it is selling relief from planning, crowds and compromise. Great Rail Journeys is leaning hard into that proposition for 2027 with two additions to its premium Landmark Collection: a Europe-heavy Orient Express and Rhône cruise pairing, plus a South Africa itinerary built around safari, Victoria Falls and rail-flavored...

Continue Reading
Alabama Power's 2027 Cut Puts Data Centers to Work

Updated Category News Views 13

Data centers rarely arrive bearing a gift for ordinary power customers. Yet Alabama Power says its coming load growth will help cut customer rates by $160 million in 2027, beginning with January bills. In a utility world stuffed with requests for more money, that is a sharp change of pace. The company filed the reduction with the Alabama Public Service Commission on Nov....

Continue Reading
Art Limitless Jury Puts SDG 12 and Art Into Clear Focus

Updated Category News Views 56

A paint pigment, a discarded object, and a serious climate question have landed in the same room. BE OPEN Art’s 2026 Art Limitless competition is aimed at SDG 12, the United Nations goal centered on responsible production and consumption. That may sound like institutional language built for conference folders, but the underlying issue is plain enough: society cannot...

Continue Reading
Boston Scientific Loads Debt Cannon for Penumbra Deal

Updated Category News Views 128

A Very Large Financing Cart Rolled Out Boston Scientific just put an enormous stack of paper into the market, and nobody should mistake this for routine housekeeping. The company priced $3.0 billion of U.S. dollar senior notes and €4.25 billion of euro notes, with proceeds earmarked chiefly for the cash portion of its proposed Penumbra acquisition, alongside cash on...

Continue Reading
S&P Global's December 8 Talk Puts Guidance in Focus

Updated Category News Views 0

A 35-minute fireside chat can be a whole lot of nothing, or it can leave a useful breadcrumb trail for shareholders willing to listen closely. S&P Global has put December 8, 2026 on the calendar, when Chief Executive Officer Martina Cheung is scheduled to appear at Goldman Sachs' 2026 Financial Services Conference in New York. Her slot runs from 5:00 p.m. to 5:35 p.m....

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Recent Options Trades in Goldman Sachs Group (GS)

Updated Category News Views 230

Bearish Sentiments in Goldman Sachs Group Options Recent activity in the financial market has brought to light the bearish stance among significant investors regarding Goldman Sachs Group (NYSE: GS). While it’s important for retail traders to stay informed, this trend signifies that something noteworthy may be unfolding within the company. Insights from Options...

Continue Reading
Calamos Investments Launches Innovative Bitcoin ETFs with Protection

Updated Category News Views 310

Calamos Investments Introduces Unique Bitcoin ETFs Offering Significant Protection Calamos Investments has recently made headlines with the launch of two groundbreaking exchange-traded funds (ETFs), designed to provide investors with innovative exposure to Bitcoin while maintaining notable downside protection. These new ETFs, namely the CBXJ and CBTJ, offer 90% and 80%...

Continue Reading
Mawson Infrastructure Group Reports Impressive Q3 Financial Gains

Updated Category News Views 192

Mawson Infrastructure Group's Notable Q3 Performance Mawson Infrastructure Group Inc. (NASDAQ: MIGI) is a technology company focused on establishing and managing advanced digital infrastructure platforms. The company recently revealed its financial and operational results, marking the conclusion of the third quarter and the year-to-date for 2025. Financial Highlights from...

Continue Reading
Nékter Juice Bar Teams Up with Krista Horton for New Smoothie

Updated Category News Views 3272

Nékter Juice Bar Launches Exciting Smoothie Collaboration The Krista Kolada Combines Clean Ingredients with Social Power Nékter Juice Bar, a leading name in providing fresh and healthy juice options, has recently rolled out a delightful new offering for its fans. The introduction of the Krista Kolada smoothie marks an exciting collaboration with lifestyle and parenting...

Continue Reading
Kintara Therapeutics Sets Record Date for Exciting CVR Issuance

Updated Category News Views 188

Kintara Therapeutics Announces Record Date for CVR Issuance Kintara Therapeutics, Inc. (NASDAQ: KTRA), a biopharmaceutical company dedicated to developing innovative therapies for solid tumors, recently revealed a record date for the issuance of Contingent Value Rights (CVRs). These rights will be granted to stockholders of Kintara as part of its forthcoming merger with...

Continue Reading